Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
31,231,281
-
Share change
-
-2,575,325
-
Total reported value
-
$48,093,608
-
Put/Call ratio
-
24%
-
Price per share
-
$1.54
-
Number of holders
-
61
-
Value change
-
-$18,733,149
-
Number of buys
-
23
-
Number of sells
-
42
Institutional Holders of MARINUS PHARMACEUTICALS INC - COM (MRNS) as of Q3 2019
As of 30 Sep 2019,
MARINUS PHARMACEUTICALS INC - COM (MRNS) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,231,281 shares.
The largest 10 holders included
Bain Capital Life Sciences Investors, LLC, Granite Point Capital Management, L.P., BlackRock Inc., Lion Point Capital, LP, VHCP Management III, LLC, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, VHCP Management II, LLC, Alyeska Investment Group, L.P., and 683 Capital Management, LLC.
This page lists
61
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.